Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
399 Cards in this Set
- Front
- Back
condensed, transcriptionally inactive chromatin that is sterically inaccessible
|
heterochromatin
|
|
less condensed, transcriptionally active, sterically accessible chromatin
|
euchromatin
|
|
Why are C-G bonds stronger than A-T bonds?
|
3 H bonds for C-G
2 H bonds for A-T |
|
Base + ribose =
|
nucleoside
|
|
base+ribose+phospate =
|
nucleotide
|
|
3x pyrimidines
|
cytosine, uracil, thymine
"CUT the PY" |
|
Purines are made from this precursor
|
inosine 5' monophosphate (IMP)
|
|
Pyrimidines are made from this precursor
|
orotate
|
|
Carbamoyl phosphate is involved in these two metabolic pathways
|
-de novo pyrimidine synthesis
-urea cycle |
|
Purine synthesis requires these 3x amino acids
|
glycine, aspartate, glutamine
|
|
hydroxyurea inhibits this element of nucleotide synthesis
(FA p.68) |
ribonucleotide reductase
|
|
6-mercaptopurine inhibits this element of nucleotide synthesis
(FA p.68) |
de novo purine synthesis
|
|
5-fluorouracil inhibits this element of nucleotide synthesis
(FA p.68) |
thymidylate synthase
|
|
Methotrexate inhibits this element of nucleotide synthesis
(FA p.68) |
dihydrofolate reductase
|
|
Trimethoprim inhibits this element of nucleotide synthesis
(FA p.68) |
*bacterial* dihydrofolate reductase
|
|
Severe combined immunodeficiency (SCID) commonly results from a deficiency of this enzyme
|
adenosine deaminase
|
|
SCID often results from a deficiency of adenosine deaminase. What is the mechanism by which this occurs? (FA 69)
|
excess ATP --> feedback inhibition of ribonucleotide reductase --> inhibition of DNA synthesis --> decreased lymphocytes
|
|
Lesch Nyhan syndrome is a disease of defective purine salvage resulting from deficiency of this enzyme
|
HGPRT
"He's Got Purine Recovery Trouble" |
|
What property of the genetic code is described below?
Each codon specifies only 1 amino acid |
Unambiguous
|
|
What property of the genetic code is described below?
More than 1 codon may code for same amino acid |
degenerate/redundant
|
|
What property of the genetic code is described below?
Code is read from a fixed starting point as a continuous sequence of bases |
Non-overlapping ("comma-less")
|
|
What property of the genetic code is described below?
Genetic code conserved throughout evolution |
Universal
|
|
A ____________ DNA mutation results in a base change in the 3rd position of a codon.
|
Silent mutation - tRNA "wobble" means that same amino acid will be used
|
|
What is tRNA wobble?
|
The base found in the third position of a codon can change without altering the amino acid that the codon represents
|
|
Point mutation in which a single nucleotide is changed, resulting in a codon that codes for a different amino acid
|
Missense mutation
|
|
A ____________ mutation results in an early stop codon
|
Nonsense
|
|
Discontinuous sequences of DNA found on the lagging strand during DNA replication
|
Okazaki fragments
|
|
sequence in the genome where DNA replication begins
|
origin of replication
|
|
Y shaped region where strands of DNA are being split apart and the leading/lagging strands are synthesized
|
replication fork
|
|
Enzyme that unwinds DNA at replication fork
|
helicase
|
|
Component of DNA replication that prevents separated DNA strands from re-annealing
|
single-stranded binding proteins
|
|
enzyme that creates a nick in the helix to relieve supercoils created during replication
|
topoisomerases
|
|
What is the action of fluoroquinolone abx?
|
inhibit DNA gyrase (type of topoisomerase)
|
|
What is the function of the primase enzyme?
|
Makes an RNA primer on which DNA Pol III can initiate replication
|
|
Prokaryotic enzyme that elongates the leading strand during DNA replication by adding nucleotides to the 3' end
|
DNA Pol III
|
|
Prokaryotic enzyme that degrades RNA primer and fills that space with DNA
|
...
|
|
Function of DNA ligase?
|
Forms the bond between neighboring Okazaki fragments on the lagging strand during DNA replication
|
|
Name the process:
endonucleases remove an oligonucleotide containing damaged bases; DNA Pol and ligase fill/reseal the gap |
nucleotide excision repair
|
|
Name the process:
During DNA replication, glycosylases recognize and remove damaged bases, empty sugar is removed, gap is filled and resealed |
Base excision repair
|
|
Name the process:
Unmethylated, newly synthesized DNA strand is proofread, mismatched nucleotides removed, gap is filled and resealed |
Mismatch repair
|
|
What hereditary condition involves defects in mismatch repair genes?
|
Hereditary non-polyposis colorectal cancer (HNPCC)
|
|
What chemical group is required in the 3' position of a nt for DNA/RNA synthesis to continue?
|
hydroxyl group
|
|
most abundant type of RNA?
|
rRNA
"Rampant, Massive, Tiny" |
|
longest type of RNA
|
mRNA
"Rampant, massive, tiny" |
|
Smallest type of RNA
|
tRNA
"Rampant, massive, tiny" |
|
mRNA start codon
|
AUG
"AUG inAUGurates protein synthesis |
|
AUG codes for...
___________ in a prokaryote ___________ in a eukaryote |
-formyl methionine (f-Met)
-methionine |
|
Site where RNA pol and other txn factors bind DNA upstream from a coding region of a gene
|
promoter
|
|
What is the result of a mutation to a promoter?
|
dramatic decrease in txn of a protein
|
|
Segment of DNA that alters gene txn by binding txn factors that promote gene expression
|
Enhancer
|
|
Site of DNA where negative regulators (repressors) bind
|
silencer
|
|
promoter, enhancer, silencer
Which of the above must be located upstream of a coding region of a gene? Why? |
PROMOTER must be upstream because RNA Pol binds there
|
|
RNA Pol I produces ___________
|
rRNA
|
|
RNA Pol II produces ___________
|
mRNA
|
|
RNA Pol III produces ___________
|
tRNA
|
|
This compound, found in death cap mushrooms, inhibits RNA Pol II. This causes liver failure if the compound is ingested
|
alpha-amanitin
|
|
Initial DNA transcript is called
|
heterogenous nucleoar RNA (hnRNA)
no 5' cap, no polyadenylation, still contains introns |
|
What processes are required for a segment of hnRNA to become mRNA (x3)?
|
-5' capping
-3' polyadenylation -splicing out of introns |
|
splicing of RNA begins when the primary transcript combines with snRNP's and other proteins to form the ______________
|
spliceosome
|
|
Different exons can be combined by ___________ ______________ to make unique proteins in different tissues
|
alternative splicing
|
|
heritable changes in phenotype or gene expression caused by mechanisms other than alterations to underlying DNA sequence
|
epigenetic changes
|
|
3-nucleotide sequence at the 3' end where the amino acid is attached to the tRNA molecule
|
CCA-OH
OH = hydroxyl group |
|
enzyme that attaches amino acid to tRNA
|
aminoacyl tRNA synthetase
|
|
two factors in *translation* responsible for accuracy of amino acid-codon genetic code
|
-aminoacyl tRNA synthetase (specific to each tRNA)
-binding of tRNA to amino-acid specific codon |
|
This antibiotic subclass binds the 30s subunit, preventing attachment of aminoacyl-tRNA
|
tetracyclines
|
|
Eukaryote or prokaryote initiation?
40S+60S --> 80S |
Eukaryote
"Even" |
|
Prokaryote or eukaryote?
30S + 50S --> 70S |
prOkaryote = "Odd"
|
|
Review steps in protein synthesis
(FA p 75) |
...
|
|
Give the term for the definition:
process by which ribosome advances 3 nts towards 3' end of RNA, moving peptidyl RNA to P site |
translocation
|
|
this tRNA site on the ribosome receives the incoming aminoacyl tRNA
|
A-site
|
|
this tRNA site on the ribosome holds the tRNA to which the growing peptide is attached
|
P-site
|
|
this tRNA site on the ribosome holds the empty tRNA before it leaves the ribosome
|
E site
|
|
this antibiotic class inhibits formation of the initiation complex (DNA tln) and causes misreading of mRNA
|
aminoglycosides
|
|
this antibiotic inhibits 50S peptidyltransferase in prokaryotes
|
chloramphenicol
|
|
these antibiotic classes (x2) bind to the 50S subunit of the bacterial ribosome, blocking translocation
|
-macrolides
-clindamycin |
|
defective proteins are tagged with ____________ to target them to the proteasome for destruction
|
ubiquitin
|
|
organelle in which steroid synthesis and detoxification of drugs/poisons occurs
|
smooth ER
|
|
site of synthesis of proteins in the secretory pathways
|
rough ER
|
|
special name for RER in neurons, which synthesizes enzymes and peptide neurotransmitters
|
Nissl bodies
|
|
Two types of cells that are rich in rough ER
|
secretory cells:
-goblet cells -plasma cells |
|
Regulatory proteins that control cell cycle events; different types of this protein depending on the stage of the cell cycle
|
Cyclins
|
|
Protein that, when bound to cyclin, phosphorylates downstream targets to move the cell through the cell cycle
|
CDK = cyclin-dependent kinase
|
|
Begin with G0, and give the subsequent four phases of the cell going through the cell cycle.
|
G1 --> S --> G2 --> M
|
|
Three phases of the cell cycle that are part of interphase
|
G1, S, G2
|
|
Rb and p53 block transition between these phases of the cell cycle
|
G1 --> S
|
|
Cell type that remains in G0; no division
|
permanent
|
|
Cell type that enters G1 from G0 only when stimulated
|
quiescent
|
|
Cell type that never goes to G0; remains in cell cycle, divides rapidly and continuously
|
labile
|
|
Distribution center of proteins and lipids from ER to the plasma membrane, lysosomes, and secretory vesicles
|
Golgi apparatus
|
|
Vesicular trafficking protein responsible for retrograde transport, from Golgi --> ER
|
COP I
|
|
Vesicular trafficking protein responsible for anterograde transport, from RER --> cis-Golgi
|
COP II
|
|
Vesicular trafficking protein responsible for moving proteins from [trans-Golgi --> lysosomes/plasma membrane --> endosomes (receptor mediated endocytosis)]
|
Clathrin
|
|
inherited lysosomal storage disorder resulting from failure of addition of *mannose-6-phosphate* to lysosome proteins
|
I-cell disease
|
|
This polysaccharide targets proteins to the lysosome
|
mannose-6-phosphate
|
|
A microtubule is a cylindrical structure composed of a helical array of dimers.
The dimers are made up of these two proteins. |
alpha and beta tubulin
|
|
These proteins transport cellular cargo towards opposite ends of the microtubule (x2)
|
dynein
kinesin |
|
molecular motor protein that transports retrograde to the microtubule (+ end towards - end)
|
dynein
|
|
molecular motor protein that transports anterograde to the microtubule (- end towards + end)
|
kinesin
|
|
microtubule polymerization defect that results in decreased phagocytosis
|
Chediak-Higashi syndrome
(p. 78) |
|
Cilia are composed of a _________ arrangement of microtubules
|
9 + 2
|
|
Kartagener's syndrome results when cilia are immotile due to a defect in this protein
|
dynein
|
|
Kartagener's syndrome results in immotile cilia due to a defect in dynein. What (somewhat predictable) effects should this demonstrate in the afflicted patient?
|
-impaired hearing
-infertility (sperm immotile) -recurrent sinusitis -bronchiectasis |
|
What effect does high cholesterol or long saturated fatty acid content have on the physical properties of a plasma membrane?
|
increased chol/long chain FA's -->
increased melting temp decreased fluidity |
|
Type of collagen found in bone, skin, tendon
|
Type I
|
|
Type of collagen found in cartilage, vitreous body, nucleus pulposus
|
Type II
|
|
Type of collagen found in skin, blood vessels, uterus, fetal tissue, granulation tissue
|
Type III
|
|
Type of collagen found in basement membranes and basal laminae
|
Type IV
"Under the floor" in lungs, kidney, vessels |
|
Two amino acid residues are hydroxylated during collagen synthesis.
Hydroxylation of this residue secures the three collagen chains in a triple helix. |
Proline
|
|
Two amino acid residues are hydroxylated during collagen synthesis.
Hydroxylation of this residue is required for covalent cross-linking to produce collagen fibrils. |
Lysine
|
|
Hydroxylation of proline and lysine residues requires this vitamin.
|
Vit C
(scurvy - vitamin C deficiency) |
|
Collagen chains in the RER, just after synthesis, are known as ___________
|
pre-pro-collagen
|
|
What is the sequence of amino acids in pre-pro-collagen?
|
Gly-X-Y
X,Y are proline, hydroxyproline, or lysine |
|
Glycosylation of residues in pre-pro-collagen results in formation of triple helix, which is known as _______________
|
pro-collagen
|
|
Procollagen is secreted into the extracellular space, where cleavage of its terminal regions transforms it into __________
|
tropocollagen
|
|
Cross-linking of tropocollagen forms ____________________
|
collagen fibrils
|
|
Inability of individual collagen chains to form the triple helix results in this heritable disease.
|
Osteogenesis imperfecta
(triple helix can't form) |
|
Failure of collagen fibrils to cross-link once they have reached the ECM results in this heritable disease.
|
Ehlers-Danlos syndrome.
|
|
This type of collagen is most frequently affected in Ehlers-Danlos syndrome
|
Type III
|
|
Three characteristic features of Ehlers-Danlos 2ry to faulty collagen synthesis:
|
1. hyperextensible skin
2. tendency to bleed (easy bruising) 3. hypermobile joints |
|
Osteogenesis imperfecta results from abnormality in this collagen subtype
|
Type I
TypeI forms bone, skin, tendon |
|
Characteristic clinical features of osteogenesis imperfecta (x4)
|
1. multiple fractures with minimal trauma
2. blue sclerae (very thin choroid) 3. hearing loss (abnormal middle ear bones) 4. dental imperfections |
|
Alport's syndrome most frequently results from a defect in this type of collagen
|
Type IV
|
|
Two important clinical features of Alport's syndrome
|
-progressive hereditary nephritis
-deafness |
|
Marfan's syndrome is caused by a defect in the _________________ protein
|
fibrillin
|
|
"stretchy protein" in the lungs, large arteries, elastic ligaments, vocal cords, and ligamenta flava
|
elastin
|
|
Elastin is composed of ___________ with ____________ scaffolding
|
-tropoelastin
-fibrillin |
|
Elastin is...
broken down by _____________ (enzyme), which is inhibited by ____________________ (enzyme) |
-elastase
-a1 antitrypsin |
|
How can a1-antitrypsin deficiency lead to emphysema?
|
a1-AT deficiency --> uninhibited elastase activity --> breakdown of elastin --> tissues supporting structure/function of lungs are destroyed (emphysema)
|
|
What is the polymerase chain reaction (PCR) used for?
|
amplify a desired fragment of DNA
|
|
Three steps of PCR
|
(1) denaturation, (2) annealing, (3) elongation
FA p. 81 |
|
This laboratory technique is used for the size separation of PCR products (smaller molecules travel further)
|
Agarose gel electrophoresis
|
|
This blotting technique is used to detect DNA samples
|
Southern blot
"SNoW DRoP" |
|
This blotting technique is used to detect RNA in a sample
|
Northern blot
"SNoW DRoP" |
|
This blotting technique is used to detect proteins in a sample
|
Western blot
"SNoW DRoP" |
|
Lab technique in which thousands of nucleic acid sequences are arranged in grids on slides; profiles expression levels of thousands of genes simultaneously
|
DNA Microarrays
|
|
rapid immunologic lab technique for testing antigen-antibody reactivity
|
ELISA = enzyme linked immunosorbent assay
|
|
What indicates a positive result in an ELISA test?
|
Usually, if the test substance is present, an intense color reaction in the test solution
|
|
In this lab technique used for specific localization of genes/direct visualization of anomalies, fluorescent DNA or RNA probes are used to bind to the site of interest
|
Fluoresence in-situ hybridization (FiSH)
|
|
What is "cloning" as a lab technique?
|
production of recombinant DNA molecule that is self perpetuating
|
|
When DNA sequences are cloned in the lab, why are the inserted into bacterial plasmids that contain resistance genes to various antibiotics?
|
Can select for the presence of the plasmid by transfecting bacteria and growing them on a medium containing the antibiotic
|
|
process in which metaphase chromosomes are stained, ordered, and numbered according to morphology, size, arm-length ratio, and banding pattern
|
karyotyping
|
|
Genetic term:
Neither of two alleles is dominant |
Codominance
|
|
Genetic term:
The nature of and severity of a particular phenotype can vary between individuals |
variable expression
|
|
Genetic term:
Not all individuals with the mutant genotype show the mutant phenotype |
incomplete penetrance
|
|
Genetic term:
one gene has >1 effect on an individual's phenotype |
Pleiotropy
|
|
Genetic term:
Differences in phenotype depend on whether the mutation is of maternal or paternal origin |
Imprinting
|
|
Genetic term:
Severity of a disease worsens or age of onset is earlier in later generations |
anticipation
|
|
Genetic term:
If a patient inherits or develops a mutation in a tumor suppressor gene, complementary allele must also be deleted/mutated before cancer can develop |
Loss of heterozygosity
|
|
Genetic term:
Heterozygote produces a nonfunctional, altered protein that prevents the normal gene product from performing its function |
Dominant negative mutation
|
|
Genetic term:
Tendency for certain alleles at two linked loci to occur more often together than expected by chance |
Linkage disequilibrium
|
|
Genetic term:
Cells in the body of the same organism do not all have the same genetic makeup |
mosaicism
|
|
Genetic term:
Mutations at different loci produce the same phenotype |
Locus disequilibrium
|
|
Genetic term:
Presence of both normal and mutated mtDNA, resulting in variable expression of mitochondrial inherited disease |
Heteroplasmy
|
|
Genetic term:
Offspring receives two copies of a chromosome from 1 parent and no copies from other parent |
Uniparental disomy
|
|
Give the Hardy-Weinberg equilibrium equations for:
(a) Disease prevalence (b) allele prevalence (c) heterozygote prevalence |
(a) p^2 + 2pq + q^2 = 1
(b) p + q = 1 (c) 2pq |
|
Biological process by which one allele at a particular locus is inactivated by methylation (such that only a single allele is active)
|
imprinting
|
|
Genetic disease resulting from delection of normally active Paternal allele on chromosome 15
|
Prader-Willi syndrome
|
|
Genetic disease resulting from a normally active Maternal allele on chromosome 15
|
AngelMan's syndrome
|
|
Autosomal dominant disorders often are due to defects in _______________ genes
|
structural
|
|
Autosomal recessive disorders often are due to defects in _______________ genes
|
enzyme
(--> enzyme deficiency or absence) |
|
Mode of inheritance of genetic disorder such that
(a) either male or female offspring of affected mother may be affected (b) all female offspring of the affected father are diseased |
X-linked dominant
|
|
X-linked dominant disorders in which increased phosphate wasting at proximal tubule leads to a rickets-like presentation
|
hypophosphatemic rickets
|
|
Mode of inheritance in which the damaged alleles can ONLY be transmitted through the mother. All offspring of affected females may show signs of the disease
|
mitochondrial inheritance
|
|
FA notes that disorders of mitochondrial inheritance have "variable expression in population due to heteroplasmy." What does this mean from a biochemical standpoint?
|
Heteroplasmy: mixture of mitochondria, some containing normal DNA and some containing mutant DNA --> proportion of normal to mutant DNA influences disease severity
|
|
AD genetic disorder:
cell signaling defect in FGF3 --> dwarfism |
Achondroplasia
|
|
Autosomal dominant:
Bilateral, massive enlargement of kidneys due to large cysts |
autosomal dominant polycystic kidney disease
|
|
Autosomal dominant:
elevated LDL due to defective or absent LDL receptor |
familial hypercholesterolemia
|
|
Autosomal dominant:
inherited disorder of blood vessels with telangiectasia, recurrent epistaxis, skin discoloration, & arteriovenous malformation |
hereditary hemorrhagic telangiectasias
|
|
another name for hereditary hemorrhagic telangiectasia
|
Osler-Weber-Rendu syndrome
|
|
Autosomal dominant:
spheroid erythrocytes due to spectrin or ankyrin defect --> hemolytic anemia |
hereditary spherocytosis
|
|
Autosomal dominant:
depression, progressive dementia, choreiform movements, atrophy of caudate nucleus, decreased GABA and ACh in the brain |
Huntington's disease
|
|
What chromosome is the gene for Huntington's located on?
|
Chromosome 4
"Hunting 4 food" |
|
What trinucleotide repeat occurs in Huntington's?
|
CAG
|
|
Marfan's syndrome involves a mutation of this gene
|
fibrillin
|
|
Autosomal dominant:
connective tissue disorder affecting skeleton, heart, eyes |
Marfan's syndrome
|
|
AD disease of the connective tissue associated subluxation of the lenses
|
Marfan's syndrome
|
|
Autosomal dominant:
familial tumors of endocrine glands |
multiple endocrine neoplasia (MEN)
|
|
Autosomal dominant:
cafe au lait spots, neural tumors, Lisch nodules, skeletal disorders, optic pathway gliomas |
Neurofibromatosis -1
|
|
Autosomal dominant:
bilateral acoustic schwannomas, juvenile cataracts |
Neurofibromatosis-2
|
|
NF2 gene located on this chromosome
|
22
|
|
NF-1 is also known as _________________
|
von Recklinghausen's disease
|
|
Autosomal dominant:
rare, multi-system genetic disease that causes non-malignant tumors to grow in the brain and on other vital organs such as the kidneys, heart, eyes, lungs, and skin. |
tuberous sclerosis
|
|
Autosomal dominant:
adenoma sebaceum, "ash leaf spots" on skin, cortical and retinal hamartomas, seizures, mental retardation, renal cysts/renal angiolipomas, cardiac rhabdomyomas, astrocytomas |
tuberous sclerosis
|
|
Autosomal dominant:
hemangioblastomas of retina/cerebellum/medulla; about half of affected individuals develop multiple bilateral renal cell carcinomas and other tumors |
von Hippel Lindau disease
|
|
von Hippel Lindau disease results 2ry to deletion of VHL gene, which results in constitutive expression of __________, as well as activation of ___________________
|
-HIF (txn factor)
-angiogenic growth factors Result is neovascularization, carcinogenesis |
|
Why are males with CF infertile?
|
Bilateral absence of vas deferens
|
|
Most common CF mutation
|
delta F508
|
|
AR defect in CFTR gene leads to an abnormality of the Cl- channel. What pathology does this cause?
|
Secretion of abnormally thick mucus that plubs lungs, pancreas, liver
|
|
Why do individuals with CF have deficiencies in fat soluble vitamins?
|
Mucus plugs in pancreas --> deficiency of digestive enzymes --> fat malabsorption
|
|
What is the normal function of the dystrophin protein?
|
connects cytoskeleton of muscle fiber to surrounding extracellular matrix
|
|
muscular dystrophy is diagnosed with these two techniques?
|
muscle bx, increased CPK (2ry to muscle breakdown)
|
|
What is the difference between Duchenne's and Becker's muscular dystrophy?
|
Duchenne's - Deleted dystrophin
Becker's - decreased or abnormal dystrophin |
|
Fragile X syndrome involves defect in this gene
|
FMR-1
|
|
Fragile X syndrome results from an expansion of this trinucleotide repeat
|
CGG
|
|
2nd most common cause of genetic mental retardation
|
Fragile X
|
|
most common cause of genetic mental retardation
|
Down's syndrome
|
|
Four TNR expansion diseases
|
Huntington's, myotonic dystrophy, Friedrich's ataxia, fragile X
|
|
What is genetic anticipation?
|
Disease severity increases and age of onset decreases in successive generations (assoc with TNR disorders)
|
|
Down's syndrome is a trisomy of chromosome _______
|
21
(Drinking age = 21) |
|
Edwards' syndrome is a trisomy of chromosome _______
|
18
(Election age = 18) |
|
Patau's syndrome is a trisomy of chromosome _______
|
13
(Puberty = 13) |
|
Autosomal trisomy:
mental retardation, flat facies, prominent epicanthal folds, simian crease, increased risk of ALL + early onset Alzheimer's disease |
Down's syndrome = trisomy 21
|
|
Most cases (95%) of Down's syndrome are due to ______________; the remainder (4%) are due to ______________.
|
-meiotic nondisjunction
-Robertsonian translocation |
|
Autosomal trisomy:
micrognathia, severe mental retardation, rocker bottom feet, clenched hands |
Edwards syndrome - trisomy 18
|
|
Autosomal trisomy:
severe mental retardation, rocker-bottom feet, cleft lip/Palate, holoprosencephaly, polydactyly |
Patau's syndrome
|
|
Name the 5 acrocentric chromosomes (chromosome whose the p (short) arm is so short that is hard to observe, but still present)
|
13, 14, 15, 21, 22
|
|
Congenital microdelection of the short arm of chromosome 5 leads to this disorder
|
Cri-du-chat syndrome
|
|
Congenital microdelection of the long arm of chromosome 7 leads to this disorder
|
Williams syndrome
|
|
Genetic disorder involving a partial chromosomal deletion that presents with:
mental disability, heart defects, "elfin facies," well-developed verbal skills and extreme friendliness with strangers |
Williams syndrome
|
|
22q11 delection syndromes cause "CATCH-22" pathology due to aberrant development of these embryonic structures
|
3rd and 4th branchial pouches
|
|
CATCH-22 pathology associated with 22q11 deletion syndromes?
|
Cleft palate
Abnormal facies Thymic aplasia --> T cell deficiency Cardiac defects Hypocalcemia 2ry to PTG aplasia |
|
22q11 deletion syndrome involving thymic, parathyroid, and cardiac defects
|
DiGeorge syndrome
|
|
22q11 deletion syndrome involving palate, facial, and cardiac defects
|
velocardialfacial syndrome
|
|
Name the four fat soluble vitamins
|
A, D, E, K
|
|
Vitamin B1 aka
|
thiamine
|
|
Vitamin B2 aka
|
riboflavin
|
|
Vitamin B3 aka
|
niacin
|
|
Vitamin B5 aka
|
pantothenic acid
|
|
Vitamin B6 aka
|
pyridoxine
|
|
Vitamin B12 aka
|
cobalmin
|
|
Vitamin C aka
|
ascorbic acid
|
|
Vitamin A aka
|
retinol
|
|
this vitamin is an antioxidant and a constituent of visual pigments; deficiency leads to night blindness and dry skin
|
vitamin A
|
|
this vitamin is required as part of thiamine pyrophosphate (TPP), a cofactor for dehydrogenase enzymes that work on alpha-ketoacids
|
B1 (thiamine)
|
|
B1 deficiency can cause this condition, which presents with confusion, ophthalmoplegia, ataxia+ confabulation, personality change, and permanent memory loss
|
Wernicke-Korsakoff syndrome
|
|
Two states in which B1 deficiency is often seen
|
-malnutrition
-alcoholism |
|
B1 deficient patients can suffer from this malnutrition syndrome, which has two subtypes
|
Beri-Beri
Dry: polyneuritis, symmetrical muscle wasting Wet: high output cardiac failure (DCM), edema |
|
B1 deficiency --> impaired glucose breakdown --> ATP depletion
Which tissues are most severely affected (x2)? |
Highly aerobic tissues = heart, brain
|
|
FAD and FMN are derived from this vitamin
|
Vit B2 - cofactor in oxidation/reduction
(riboFlavin --> FAD, FMN) |
|
Inflammation of the lips, scaling/fissures at the corners of the mouth, and corneal vascularization are called _____________ and seen in patients deficient in vitamin ______
|
-cheilosis
-B2 |
|
NAD/NADP are derived from this vitamin
|
Vit B3 (niacin)
*N*iacin --> Nad/Nadp |
|
Vit B3 (niacin) is derived from this amino acid
|
tryptophan
|
|
synthesis of Vit B3 (niacin) requires this vitamin
|
B6 (pyridoxine)
|
|
Regarding Vit B3 (niacin):
a. mild deficiency --> (?) b. severe deficiency --> (?) |
a. glossitis
b. pellagra (3 D's) = diarrhea, dermatitis, dementia |
|
How can each of the following lead to Vit B3 (niacin) deficiency?
a. Hartnup disease b. carcinoid syndrome c. INH therapy |
a. dec TRP absorption
b. inc TRP metabolism c. dec Vit B6 |
|
Other than to correct deficiency, why might Vit B3 (niacin) be given therapeutically?
|
Bridge to GI:
Niacin inhibits lipolysis in adipose tissue --> used as a lipid-lowering agent |
|
What side effect occurs with excess Vit B3 (niacin)?
|
Facial flushing (occurs with pharmacologic doses for tx of hyperlipidemia)
|
|
This vitamin is an essential component of both (1) CoA (cofactor for acyl transfers) and (2) fatty acid synthase
|
Vit B5 (pantothen*ate*)
Pantothen-*A* is found in Co-A |
|
This vidamin is converted to pyridoxal phosphate, a cofactor in various reactions
|
Vit B6 (pyridoxine)
|
|
Why does a deficiency in vit B6 (pyridoxine) cause convulsions?
|
B6 --(conversion)--> pyridoxal phosphate
Pyridoxal phosphate required for synthesis of GABA, 5-HT, NE, and EPI synthesis |
|
Deficiency of either of these vitamins leads to macrocytic anemia
|
Folate, B12
|
|
Deficiency in this vitamin leads to megaloblastic anemia and neurologic sx
|
B12
Subacute combined degeneration - demyelination of dorsal columns, LCST |
|
A patient presents with vit B12 deficiency. Is this likely to be nutritional in nature?
|
No. A very large reserve pool (several years' worth) is stored in the liver. Deficiency can result from malabsorption (sprue, fish tapeworm), lack of intrinsic factor (pernicious anemia, gastric bypass), or absence of terminal ileum.
|
|
A patient presents with folate deficiency. Is this likely to be nutritional in nature?
|
Yes, only a very small pool of folate exists. Found in green leaves.
Deficiency most pronounced in pregnant women and alcoholics. |
|
A patient has macrocytic anemia. What physical exam finding can be used to differentiate between folate and B12 deficiency?
|
Neurologic sx = B12
No neurologic sx = folate Patients with B12 deficiency experience subacute combined degeneration, a demyelinating disease of the dorsal columns and LCST |
|
This test is used to determine etiology of B12 deficiency.
|
Schilling test
|
|
B12 is a cofactor for this enzyme
|
homocysteine methyltransferase
|
|
What compound serves as the "methyl donor man" in the conversion of methionine to homocysteine?
|
SAM "the methyl donor man"
SAM = S-adenosyl-methionine = ATP + methionine |
|
Folate deficiency in pregnancy can have this adverse consequence
|
neural tube defects
|
|
This vitamin is a cofactor for carboxlation enzymes
|
Vit B7 (Biotin)
|
|
Biotin aka
|
vit B7
|
|
Three functions of vitamin C:
a. facilitates absorption of _________ b. necessary for _______________ during collagen synthesis c. necessary for the conversion of ________ to _________ |
a. iron (keeps iron in the Fe2+ state)
b. hydroxylation of proline/lysine residues c. dopamine to NE |
|
deficiency of vitamin C is called
|
scurvy
defective collagen synthesis --> impaired wound healing, poor bone formation, fragile capillaries |
|
Why does excessive ingestion of raw eggs lead to biotin (Vit B7) deficiency?
|
Raw eggs contain AVIDIN, which binds biotin.
|
|
Give the alternate names for the compounds below
a. D2 = b. D3 = |
a. D2 = ergocalciferol
b. D3 = cholecalciferol |
|
What is the primary function of Vitamin D?
|
increased intestinal absorption of calcium and phosphate
|
|
Vit D deficiency is called __________ in children, and __________ in adults
|
RICKETS in children, OSTEOMALACIA in adults
|
|
Excess vitamin D can be seen in this systemic disease, 2ry to increased activation of Vit D by epithelioid macrophages
|
sarcoidosis
|
|
This vitamin is an antioxidant, and protects erythrocytes and cell membranes from free radical damage
|
Vitamin E
|
|
What is the hematologic consequence of Vit E deficiency?
|
hemolytic anemia
Vit E deficiency --> decreased protection of erythrocytes from free radical damage --> inc erythrocyte fragility |
|
This vitamin is a cofactor for gamma carboxylation of glutamic acid residues
|
Vitamin K
|
|
What is the source of vitamin K?
|
endogenous intestinal flora
|
|
Why are neonates susceptible to vitamin K deficiency?
|
Intestine is sterile --> normal flora required for VitK synthesis
|
|
Why are individuals taking antibiotics susceptible to vitamin K deficiency?
|
ABX --> death of intestinal flora --> decreased vitK production
|
|
Vit K is necessary for the synthesis of these clotting factors
|
II, VII, IX, and X ("1972 = ten, nine, seven, and two")
Proteins C and S |
|
ethanol --(1)--> acetaldehyde --(2)--> acetate
a. What enzyme is responsible for conversion (1)? b. For conversion (2)? |
a. alcohol dehydrogenase
b. acetaldehyde dehydrogenase |
|
ethanol --(1)--> acetaldehyde --(2)--> acetate
reaction (1) takes place where? reaction (2) takes place where? |
(1) cytosol
(2) mitochondria |
|
ethanol --(1)--> acetaldehyde --(2)--> acetate
methanol --(1)--> b. _____________ --(2)--> c. _____________ When a person drinks methanol, what compounds appear (via the same metabolic pathway as ethanol) in blanks b and c? |
b. formaldehyde
c. formic acid Formaldehyde is highly toxic to humans |
|
methanol --(1)--> formaldehyde --(2)--> formate
This medication inhibits alcohol dehydrogenase (1) and is the antidote for methanol/ethylene glycol poisoning |
fomepizole
|
|
ethanol --(1)--> aldehyde --(2)--> acetate
this medication inhibits acetaldehyde dehydrogenase (2), leading to accumulation of acetaldehyde |
disulfuram
*acetaldehyde* is the compound responsible for hangovers -- with disulfuram, it accumulates more quickly, resulting in unpleasant sx (used to treat alcohol addiction) |
|
Limiting reagent in EtOH metabolism
|
NAD+
ethanol --------------------->acetaldehyde | NAD+ ----> NADH |
|
Ethanol metabolism increases NADH/NAD ratio in liver --> causes (1) pyruvate to lactate, (2) OAA to malate
Reactions (1) and (2) convert NADH to NAD. However, as a consequence, certain processes are altered: __________ is inhibited and ___________ is stimulated. |
-gluconeogenesis inhibited
-fatty acid synthesis stimulated |
|
Metabolism of large amounts of ethanol impairs gluconeogenesis and stimulates fatty acid synthesis. What are the pathological consequences of these metabolic changes?
|
impaired gluconeo --> hypoglycemia
stimulated FA synthesis --> hepatocellular steatosis |
|
Protein malnutrition results in this condition characterized by skin lesions, edema, and liver malfunction.
Presentation: small child with swollen abdomen |
kwashiorkor
|
|
Total calorie malnutrition results in this condition characterized by tissue and muscle wasting, loss of subcutaneous fat
|
marasmus
|
|
Why do patients with kwashiorkor have a swollen abdomen?
|
protein deficiency --> liver malfunction --> decreased albumin --> decreased oncotic pressure --> ASCITES
|
|
Consider the following metabolic processes: Fatty acid oxidation, acetyl-CoA production, TCA cycle, oxidative phosphorylation
In what location do these take place? |
mitochondria
|
|
Consider the following metabolic processes: Glycolysis, fatty acid synthesis, HMP shunt, protein synthesis, steroid synthesis.
In what location do these take place? |
Cytoplasm
|
|
Which 3x metabolic processes have steps occurring in both the mitochondria and the cytoplasm?
|
heme synthesis, urea cycle, gluconeogenesis
"HUGs take two" |
|
This enzyme class adds high-energy phosphates to substrates
|
kinase
|
|
This enzyme class adds inorganic phosphate onto a substrate without using ATP
|
phosphorylase
|
|
enzyme that removes a phosphate group from a substrate
|
phosphatase
|
|
enzyme that *oxidizes* a substrate
|
dehydrogenase
|
|
enzyme that adds 1 carbon with biotin as a cofactor
|
carboxylase
|
|
Rate determining enzyme for glycolysis
|
phosphofructokinase-1
|
|
Rate determining enzyme for gluconeogenesis
|
fructose-1,6-bisphosphatase
|
|
Rate determining enzyme for TCA cycle
|
isocitrate dehydrogenase
[isocitrate --> a-ketoglutarate] |
|
Rate determining enzyme for glycogen synthesis
|
glycogen synthase
|
|
Rate determining enzyme for glycogenolysis
|
glycogen phosphorylase
|
|
Rate determining enzyme for HMP shunt
|
glucose-6-phosphate dehydrogenase
|
|
Rate determining enzyme for [de novo pyrimidine synthesis]
|
Carbamoyl phosphate synthetase II
|
|
Rate determining enzyme for de novo purine synthesis
|
Glutamine PRPP amidotransferase
|
|
Rate determining enzyme for urea cycle
|
Carbamoyl phosphate synthetase I
|
|
Rate determining enzyme for fatty acid synthesis
|
Acetyl CoA carboxylase (ACC)
|
|
Rate determining enzyme for fatty acid oxidation
|
Carnitine acyltransferase I
|
|
Rate determining enzyme for ketogenesis
|
HMG-CoA synthase
|
|
Rate determining enzyme for cholesterol synthesis
|
HMG-CoA reductase
(target of statins) |
|
How many NET ATP are produced by glycolysis?
|
+2 net
|
|
How many NET ATP are produced by aerobic respiration per cycle?
|
+30-32 net ATP
|
|
a-ketoglutarate is an intermediate in the TCA cycle
in what way can hyperammonemia cause an a-KG deficiency that inhibits the TCA cycle? |
a-KG is required for transfer of waste nitrogen to urea for excretion; hyperammonemia can cause a-KG depletion due to increased demand in nitrogen disposal pathway.
|
|
in what organs does glycolysis/ATP production use the *malate-aspartate* shuttle?
|
heart, liver
|
|
in what organ does glycolysis/ATP production use the *glycerol-3-phosphate* shuttle?
|
muscle
|
|
NADPH is a product of this metabolic pathway
|
Hexose-monophosphate (HMP) shunt
|
|
This nicotinamide compound is used in *catabolic* processes to carry away reducing equivalents
|
NAD+ (--> NADH)
|
|
This nicotinamide compound is used in anabolic processes (steroid and FA synthesis) as a supply of reducing equivalents
|
NADPH
|
|
Name four important cellular processes for which NADPH is essential:
|
1. anabolic processes
2. respiratory burst (ROS release from immune system cells) 3. P-450 system metabolism 4. Glutathione reductase (important antioxidant) |
|
hexokinase and glucokinase perform the same function, but in different places - where is hexokinase found vs glucokinase?
|
hexokinase - ubiquitous
glucokinase - liver and B cells of pancreas "G for GI only" |
|
After a meal, glucokinase performs this action to sequester excess glucose in the liver
|
phosphorylates excess glucose
|
|
does hexokinase have feedback inhibition?
|
inhibited directly by glucose 6 phosphate
|
|
does glucokinase have feedback inhibition from any downstream compounds?
|
no direct feedback inhibition
|
|
glucokinase (liver) is induced by this compound
|
insulin
|
|
What is the difference between glucokinase and hexokinase in terms of affinity (Km)/capacity (Vmax) for glucose?
|
glucokinase: low affinity, high capacity
hexokinase: high affinity, low capacity |
|
write out the net glycolysis reaction
|
Glucose + 2Pi + 2 ADP + 2 NAD+ --> 2 pyruvate + 2 ATP + 2 NADH + 2 (H+) + 2 H2O
|
|
What is the function of fructose-2,6-bisphosphate?
|
Accelerates conversion of F-6-P to F-1,6-bisP
(rate limiting step in glycolysis) |
|
what is the function of fructose bisphosphatase 2?
|
converts F-2,6-bisP to F-6-P
(active when fasting) |
|
what is the function of phosphofructokinase 2?
|
converts F-6-P to F-2,6-bisP
|
|
fructose bisphosphatase 2 is upregulated in the fasting state. what compound is responsible for this change?
|
inc glucagon
|
|
phosphofructokinase-2 is upregulated in the fed state. what compound is responsible for this change?
|
insulin
|
|
the pyruvate and a-ketoglutarate dehydrogenase complexes have 3 enzymes that require the same five cofactors:
|
1. pyrophosphate
2. FAD 3. NAD 4. CoA 5. Lipoic acid |
|
How does ARSENIC disrupt normal cell metabolism?
|
interferes with lipoic acid, one of the cofactors of the pyruvate- and a-KG dehydrogenase complexes
|
|
pyruvate dehydrogenase deficiency --> increased conc of pyruvate and alanine --> (metabolic disturbance?)
|
lactic acidosis
|
|
Given what you know about the five cofactors for pyruvate and a-KG dehydrogenase complexes, why might an alcoholic be deficient in these enzymes?
|
Alcoholics: thiamine (B1) deficiency
|
|
Pyruvate --> lactate --> _______
|
Cori cycle
|
|
Pyruvate --> Acetyl CoA --> _______
|
TCA cycle
|
|
Pyruvate --> Oxaloacetate --> _______ (x2)
|
-TCA cycle
-gluconeogenesis |
|
Pyruvate --> Alanine --> glutamate --> _______
|
urea cycle
|
|
3x irreversible enzymes of TCA cycle
|
-citrate synthase
-isocitrate dehydrogenase -aKG dehydrogenase |
|
Where do TCA cycle reactions occur?
|
mitochondria
|
|
electrons carried by NADH from glycolysis and the TCA cycle can enter mitochondria by either of these two pathways
|
malate-aspartate shuttle
glycerol-3-phosphate shuttle |
|
A concentration gradient of this ion, produced by the electron transport chain, drives formation of ATP
|
H+
|
|
Protein in the ETC where NADH donates electrons recovered from glycolysis/TCA cycle
|
Complex I
|
|
Protein in the ETC where FADH2 donates electrons recovered from glycolysis/TCA cycle
|
Complex II (succinate dehydrogenase)
|
|
How do the following compounds interfere with normal oxphos?
Rotenone, CN-, antimycin A, CO |
electron transport inhibitors --> decreased H+ gradient --> blocked ATP synthesis
|
|
How do the following compounds interfere with normal oxphos?
Oligomycin |
ATPase inhibition --> increased proton gradient, no ATP
|
|
How do the following compounds interfere with normal oxphos?
2,4-dinitrophenol, aspirin, thermogenin |
Uncoupling agents --> inc permeability of inner mitochondrial membrane --> decreased proton gradient, increased O2 consumption --> no ATP synthesis, but HEAT produced
|
|
Name the four irreversible enzymes in gluconeogenesis
"Pathway Produces Fresh Glucose" |
Pyruvate carboxylase
PEP carboxykinase Fructose-1,6-bisphosphatase Glucose-6-phosphate |
|
Pyruvate carboxylase requires these two cofactors
|
biotin, ATP
(converts pyruvate --> oxaloacetate) |
|
pyruvate carboxylase is found where?
|
mitochondria
|
|
PEP carboxykinase is found where?
|
cytosol
|
|
what is the function of PEP carboxykinase?
|
oxaloacetate --> phosphoenol pyruvate
|
|
what is the function of fructose 1,6 bisphosphatase?
|
converts F-1,6-bisP --> F-6-P
|
|
Gluconeogenesis primarily occurs in this organ
|
liver
|
|
three primary substrates for gluconeogenesis
|
lactate, glycerol, glucogenic amino acids
|
|
What is the purpose of the hexose monophosphate shunt?
|
HMP shunt...
-produces NADPH from glucose-6-phosphate -ribose for nucleotide synthesis No ATP used or produced |
|
Two distinct phases of the HMP shunt
|
oxidative
non-oxidative |
|
oxidative reaction of HMP shunt produces (x3)?
|
CO2, NADPH, ribulose-5-P
|
|
non-oxidative reaction of HMP shunt produces (x3)?
|
ribulose-5-P, G3P, F6P
(NADPH only produced by oxidative reaction) |
|
The respiratory burst involves the action of this membrane protein
|
NADPH oxidase
|
|
What two cell types have a respiratory burst?
|
neutrophils, macrophages
|
|
Respiratory burst produces this product
|
reactive oxygen species
|
|
NADPH oxidase deficiency --> no respiratory burst --> (disease?)
|
chronic granulomatous disease
|
|
NADPH is necessary for the reduction of this compound, which is used by the cell to detoxify free radicals and peroxides
|
glutathione
|
|
Why does a glucose-6-phosphate dehydrogenase deficiency lead to hemolytic anemia?
|
G6PD is necessary for the HMP shunt, which produces NADPH.
With less NADPH, RBC's have poor defense against free radicals --> membrane damage --> cell lysis |
|
oxidized Hgb precipitated within RBC's
|
Heinz bodies
|
|
microscopic appearance of RBCs after phagocytic removal of Heinz bodies by splenic macrophages
|
bite cells
|
|
First enzyme in the pathway by which fructose enters glycolysis
|
fructokinase
|
|
Disease in which fructokinase (first enzyme in the pathway by which fructose enters glycolysis) is defective?
|
essential fructosuria
(benign, asymptomatic condition - fructose appears in blood or urine...) |
|
[Fructose-1-P --> DHAP + glyceraldehyde]
A deficiency in what enzyme disrupts the above reaction? |
Aldolase B
|
|
In fructose intolerance (aldolase B deficiency), what is the biochemical mechanism of inhibition of gluconeogenesis and glycogenolysis?
|
No aldolase-B --> F-1-P accumulates --> decrease in available phosphate --> inhibition of reactions (as above)
|
|
a person who is fructose intolerant has a deficiency in aldolase B. treatment involves restricting intake of these two carbohydrate compounds:
|
-fructose
-sucrose (= glucose + fructose) |
|
galactose --(enzyme A)--> gal-1-P --(enzyme B)--> G-1-P
What are enzymes A and B? |
A: galactokinase
B: uridyl transferase |
|
galactose --(galactokinase)--> gal-1-P
If a person has a galactokinase deficiency, what happens to all that accumulating galactose? |
galactose --(aldose reductase)--> galactitol
increased concentrations of galactose and galactitol cause poor growth, jaundice, infant cataracts, mental retardation |
|
galactokinase deficiency: what carbohydrates must be restricted to avoid complications of the disease?
|
-galactose
-lactose (=glucose + galactose) |
|
In conditions of extremely high blood glucose, the body may try to trap glucose in cells as this compound, the alcohol counterpart of glucose.
|
sorbitol
|
|
Glucose --(enzyme A)--> sorbitol --(enzyme B)--> fructose
What are enzyme A and B? |
A: aldose reductase
B: sorbitol dehydrogenase |
|
In conditions of extremely high [glucose] in blood, why are Schwann cells, the lens, the retina, and the kidneys at risk of damage?
|
cells in these structures possess aldose reductase, meaning that they convert glucose to sorbitol
however, they have no mechanism to convert sorbitol to fructose, so sorbitol accumulates --> influx of H2O --> osmotic damage |
|
In conditions of hyperglycemia, what organs are most susceptible to damage?
|
glucose --(aldose reductase)--> sorbitol accumulation --> osmotic damage
lens of eye (cataracts), retina (retinopathy), Schwann cells (peripheral neuropathy) |
|
Which optical isomer of amino acids is found in proteins?
|
L amino acids
|
|
Name the four glucogenic amino acids
|
Met Val Arg His
|
|
Name the four glucogenic/ketogenic amino acids
|
Ile Phe Trp Thr
|
|
Name the two ketogenic AAs
|
Leu Lys
|
|
Acidic amino acids (negatively charged at body pH) x2
|
Asp Glu
|
|
Basic amino acids x3 = positively charged at body temp
|
Arg, Lys, His
|
|
Most basic amino acid
|
Arg
|
|
These two amino acids are esp concentrated in histone proteins
|
Arg, Lys
histones must be positively charged to bind negatively charged DNA |
|
Mnemonic for TCA cycle
"Our City Is Kept Safe And Sound From Malice" |
Oxaloacetate --> citrate --> isocitrate --> a-ketoglutarate --> succinyl CoA --> succinate --> fumarate --> malate
|
|
What is the purpose of the urea cycle?
|
amino acid catabolism --> production of excess NH4
Urea cycle: excess NH4 converted to urea for excretion in urine |
|
Rate limiting enzyme in the urea cycle:
CO2 + NH4 --(enzyme?)--> carbamoyl phosphate |
carbamoyl phosphate synthetase I
(CPS II is rate-limiting for de novo pyrimidine synthesis) |
|
Four compounds cycling in the urea cycle:
|
citrulline --> arginosuccinate --> arginine --> ornithine
(FA p. 105 for diagram) |
|
Two compounds which constantly feed into the urea cycle
|
carbamoyl phosphatase, Asp
(FA p. 105 for diagram) |
|
Which compound entering the urea cycle contains the excess nitrogen?
|
carbamoyl phosphatase
(FA p. 105 for diagram) |
|
enzyme that transports carbamoyl phosphate out of the mitochondrion as part of the urea cycle
|
ornithine transcarbamoylase
|
|
most common urea cycle disorder
|
ornithine transcarbamoylase (OTC) deficiency
|
|
What is interesting about the inheritance pattern of OTC deficiency vs other urea cycle deficiencies?
|
OTC deficiency: XLR
other urea cycle deficiencies: AR |
|
What are the metabolic consequences of OTC deficiency?
|
excess carbamoyl phosphate --> excess orotic acid (blood, urine)
can't eliminate nitrogenous waste --> ammonia intoxication |
|
see p. 106 in FA 2011 - write out each of the pathways for derivatives from important amino acids
|
...
|
|
amino acid precursor to tyrosine
|
Phe
|
|
tyrosine converted to DOPA by this enzyme
|
tyrosine hydroxylase
|
|
DOPA converted to dopamine by this enzyme
|
DOPA decarboxylase
|
|
DA --(enzyme?) --> NE
|
dopamine B-hydroxylase
|
|
NE --(enzyme?)--> EPI
|
phenylethanolamine N-methyl transferase (PNMT)
|
|
homovanyllic acid is a breakdown product of this compound
|
dopamine
|
|
vanillylmendelic acid is a breakdown product of this compound
|
NE
|
|
metanephrine is a breakdown product of this compound
|
epinephrine
|
|
What is the general function of SAM (s-adenyl methionine)?
|
methyl donor
|
|
What is phenylketonuria?
|
Absence of the enzyme that converts [Phe --> Tyr]
Result: must decrease Phe intake, Tyr becomes essential |
|
Inheritance of phenylketonuria?
|
AR
|
|
What is the treatment for phenylketonuria?
|
Phe --||--> Tyr
decrease Phe consumption increase Tyr consumption (Tyr becomes essential) |
|
two enzymes that break down catecholamines
|
MAO, COMT
|